In conclusion, PCSK9-i treatment significantly increased ABCG1-mediated HDL-CEC as well as CEC by the aqueous diffusion pathway and it reduced serum CLC in a cohort of FH subjects. The gene discussed is PCSK9; the disease is familial hyperaldosteronism.